Evidence map›Paper›PMID 29296159›Full record

ReviewThe Pan African medical journal2017

Progress towards achieving and maintaining maternal and neonatal tetanus elimination in the African region.

Alison Delano Ridpath, Heather Melissa Scobie, Messeret Eshetu Shibeshi, Ahmadu Yakubu, Flint Zulu, Azhar Abid Raza, Balcha Masresha, Rania Tohme

Open access · goldAbstract readReview
In one paragraph

Review in The Pan African medical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Maternal and Neonatal Tetanus Elimination: Where are We Now?Research and reports in tropical medicine · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Alison Delano RidpathCenters for Disease Control and Prevention, Global Immunization Division, Atlanta, GA, USA.
Heather Melissa ScobieCenters for Disease Control and Prevention, Global Immunization Division, Atlanta, GA, USA.
Messeret Eshetu ShibeshiWorld Health Organization, Intercountry Support Team for East and Southern Africa, Harare, Zimbabwe.
Ahmadu YakubuWorld Health Organization, Family, Women and Children's Health Cluster, Geneva, Switzerland.
Flint ZuluUnited Nations Children's Fund, Health Section, Program Division, New York, NY, USA.
Azhar Abid RazaUnited Nations Children's Fund, Health Section, Program Division, New York, NY, USA.
Balcha MasreshaWorld Health Organization, Intercountry Support Team for East and Southern Africa, Harare, Zimbabwe.
Rania TohmeCenters for Disease Control and Prevention, Global Immunization Division, Atlanta, GA, USA.
Centers for Disease Control and Prevention · USUnited Nations Children's Fund · USWorld Health Organization - Zimbabwe · ZWWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

Despite the availability of effective tetanus prevention strategies, as of 2016, Maternal and Neonatal Tetanus Elimination (MNTE) has not yet been achieved in 18 countries globally. In this paper, we review the status of MNTE in the World Health Organization African Region (AFR),and provide recommendations for achieving and maintaining MNTE in AFR. As of November 2016, 37 (79%) AFR countries have achieved MNTE, with 10 (21%) countries remaining. DTP3 coverage increased from 52% in 2000 to 76% in 2015. In 2015, coverage with at least 2 doses of tetanus containing vaccine (TT2+) and proportion of newborns protected at birth (PAB) were 69% and 77%, compared with 44% and 62% in 2000, respectively. Since 1999, over 79 million women of reproductive age (WRA) have been vaccinated with TT2+ through supplementary immunization activities (SIAs). Despite the progress, only 54% of births were attended by skilled birth attendants (SBAs), 5 (11%) countries provided the 3 WHO-recommended booster doses to both sexes, and about 5.5 million WRA still need to be reached with SIAs. Coverage disparities still exist between countries that have achieved MNTE and those that have not. In 2015, coverage with DTP3 and PAB were higher in MNTE countries compared with those yet to achieve MNTE: 84% vs. 68% and 86% vs. 69%, respectively. Challenges to achieving MNTE in the remaining AFR countries include weak health systems, competing priorities, insufficient funding, insecurity, and sub-optimal neonatal tetanus (NT) surveillance. To achieve and maintain MNTE in AFR, increasing SBAs and tetanus vaccination coverage, integrating tetanus vaccination with other opportunities (e.g., polio and measles campaigns, mother and child health days), and providing appropriately spaced booster doses are needed. Strengthening NT surveillance and conducting serosurveys would ensure appropriate targeting of MNTE activities and high-quality information for validating the achievement and maintenance of elimination.

Indexed as

AfricaDisease EradicationFemaleHumansImmunization ScheduleInfant, NewbornInfant, Newborn, DiseasesMalePregnancyTetanusTetanus ToxoidVaccinationVaccination CoverageWorld Health OrganizationTetanus ToxoidAfricaimmunizationtetanus

Identifiers

PMID29296159
PMCPMC5745942
OpenAlexW2630889265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.